Analyst Ratings for Rocket Pharmaceuticals (RCKT) [Sells]
RCKT Rating Summary
RCKT Price Target Summary
- Highest: $65.00 (Cantor Fitzgerald)
- Lowest: $9.00 (JPMorgan)
- Average: $44.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$44.00 (+85.8%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$44.00 (+85.8%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/18/2020 | Keefe, Bruyette & Woods | Bose T. George | Downgrade | Underperform (Market Perform) |
19.00 (N/A) |
54.83 (23.68) |
-56.81% | Details |
